World medical trendsNovember 19, 2020
At the online conference, the participants discussed innovative methods of diagnosing allergic diseases, biological therapy issues and current researches on the functioning of immunity in COVID-19 patients. Particular attention was paid to the project to study the protective role of atopic bronchial asthma in COVID-19, which is being implemented jointly with Harald Renz, Professor of the Department of Clinical Immunology and Allergology at Sechenov University, within the framework of Project 5-100. The Head of the Department of Clinical Immunology and Allergology, Head of the Laboratory of Immunopathology of Sechenov University, Academician of the Russian Academy of Sciences Alexander Karaulov spoke at the event.
“For 30 years the department has been a major educational and scientific center in the field of clinical immunology and allergology. Training of students, residents, postgraduates, as well as professional retraining and advanced training of doctors, is carried out. The area of expertise of the department staff, in addition to allergology and immunology, covers many branches of medicine - therapy, pediatrics, pulmonology, oncology, dermatology, ophthalmology, and others. The staff and graduate students of the department are actively conducting joint scientific work with domestic and foreign universities in several areas,” - he said.
Alexander Karaulov also made a presentation "Prevention and treatment of COVID-19: immunological aspects" at the symposium "COVID 19 and not only", which was held by Sechenov University on November 17-18, 2020. The first presentation of the main scientific agenda of the forum was devoted to the main topic of this year - the COVID-19 pandemic. Alexander Lukashev, Director of the Institute of Medical Parasitology, Tropical and Transmissible Diseases named after E.I. Marcinovsky Sechenov University, shared the information known to scientists about the virus at the moment, as well as the most likely scenarios for the development of events. According to the expert, much depends on how stable the immunity will be after the disease and vaccination.
The reports on the development of exoskeletons for the recovery of patients after injuries and strokes, the treatment of complex bacterial infections, care for newborns, the creation of personalized implants, and tests for the detection of antibodies to SARS-CoV-2 were made at the forum. Within two days, scientists from Russia and the USA, Germany, and France, Great Britain, China, and other countries presented more than 70 reports on the latest advances in bioengineering, regenerative medicine, personalized and translational medicine. These topics are leading world trends and correspond to the scientific agenda, which is being implemented by Sechenov University, including with the support of Project 5-100.
Summing up the results of the symposium, Rector of the Sechenov University, Academician of the Russian Academy of Sciences Pyotr Glybochko expressed his confidence that the exchange of knowledge on the site of the Sechenov Biomedical Summit will help lay the foundation for new projects and form new teams of researchers that will help in solving the most ambitious problems in modern biomedicine.